Epigenetic similarity between adenoid ameloblastoma and dentinogenic ghost cell tumour: DNA methylation analysis in odontogenic tumours [0.03%]
牙源性肿瘤中的DNA甲基化分析：成釉细胞瘤和牙本质鬼细胞瘤的表观遗传相似性
Kyu-Young Oh
Kyu-Young Oh
Although adenoid ameloblastoma (AA) has recently been included in the WHO classification as a separate tumour type, its clinical, histological, immunohistochemical, and molecular similarities to dentinogenic ghost cell tumour (DGCT) raise q...
Decoding UTROSCT heterogeneity: systematic clinicopathological evaluation combined with molecular profiling [0.03%]
UTROSCT异质性的解析：系统临床病理学评估与分子分型相结合
Jing Yang,Jinku Zhang,Jinmei Li et al.
Jing Yang et al.
Uterine tumor resembling ovarian sex cord tumor (UTROSCT) constitutes an exceptionally rare histological subset of uterine mesenchymal neoplasms. While most cases have benign clinical behavior, a subset of UTROSCTs exhibits clinically aggre...
Chuqi Pan,Silin Xiang,Mengya Jiang et al.
Chuqi Pan et al.
This study characterizes a novel disease pattern of membranous nephropathy (MN) that exhibits overlapping clinicopathological features with minimal change disease (MCD), termed 'MCD-like MN'. Patients with histologically confirmed MN showin...
Characterisation and impact of intratumoural stroma in melanoma and carcinoma brain metastases [0.03%]
黑色素瘤和癌脑转移内肿瘤间质的特征及影响
Dave Bandke,Serge Weis,Andreas Gruber et al.
Dave Bandke et al.
Research on the tumour microenvironment in brain metastases (BM) has predominantly focused on the immune response, while the presence, morphological patterns, and potential clinical relevance of intratumoural stroma remain less intensively ...
Development of a decision tree diagram for classifying study designs in tumour pathology research: a multidisciplinary approach [0.03%]
一种用于肿瘤病理学研究的决策树图的发展：一种多学科的方法以对研究设计进行分类
Oana M Craciun,Ester García-Ovejero,Fiona Campbell et al.
Oana M Craciun et al.
The World Health Organization (WHO) Classification of Tumours: A Living Evidence Gap Map by Tumour Type (WCT EVI MAP) project aims to develop Evidence Gap Maps of the available evidence, primarily to inform the WHO Classification of Tumours...
The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution [0.03%]
髓系肉瘤治疗之路：探索亚克隆MAPK/ERK突变和克隆进化复杂性的导航地图
DuJiang Yang,Jiexiang Yang,GuoYou Wang
DuJiang Yang
B lymphocytes and tertiary lymphoid structures have a prognostic impact on penile squamous cell carcinoma [0.03%]
伯基特淋巴瘤和三级淋巴组织结构对阴茎鳞状细胞癌的预后有影响
Nicolette Zavillová,Petr Waldauf,Michaela Kendall Bártů et al.
Nicolette Zavillová et al.
Several prognostic markers, including tumor-infiltrating lymphocytes, which have been recently identified in penile squamous cell carcinoma (pSCC), have focused mostly on T cells. The prognostic role of B cells and tertiary lymphoid structu...
Secretory breast carcinoma: morphologic and molecular heterogeneity with indicators of aggressive potential in a cohort of 29 cases [0.03%]
分泌性乳腺癌：39例的形态及分子异质性并具有侵袭潜能指标
Huayan Ren,Wanting Tong,Jiayue Ma et al.
Huayan Ren et al.
Secretory breast carcinoma (SBC) is a rare tumour defined by ETV6-NTRK3 rearrangement, but its clinicopathological spectrum and potential for aggressive behaviour remain incompletely characterised. We retrospectively reviewed 29 SBCs diagno...
Context is key: how diagnostic and prognostic markers are reshaping gynecologic pathology [0.03%]
上下文是关键：诊断和预后标志物如何重塑妇科病理学
Martin Köbel,Anthony N Karnezis
Martin Köbel
The field of gynecologic pathology is undergoing a transformative change. The translation of molecular findings from large-scale genomic studies into clinical practice has been facilitated by robust surrogate assays, particularly immunohist...